Nanomaterial Delivery Systems for mRNA Vaccines

The recent success of mRNA vaccines in SARS-CoV-2 clinical trials is in part due to the development of lipid nanoparticle delivery systems that not only efficiently express the mRNA-encoded immunogen after intramuscular injection, but also play roles as adjuvants and in vaccine reactogenicity. We pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Buschmann, Michael D., Carrasco, Manuel J., Alishetty, Suman, Paige, Mikell, Alameh, Mohamad Gabriel, Weissman, Drew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836001/
https://www.ncbi.nlm.nih.gov/pubmed/33478109
http://dx.doi.org/10.3390/vaccines9010065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836001/
https://www.ncbi.nlm.nih.gov/pubmed/33478109
http://dx.doi.org/10.3390/vaccines9010065

Ejemplares similares